Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends

J Infect Dis. 1992 Mar;165(3):577-80. doi: 10.1093/infdis/165.3.577.

Abstract

To evaluate the incidence of disseminated Mycobacterium avium complex infection (DMAC) and to define the association between signs and symptoms and development of DMAC in patients with human immunodeficiency virus (HIV) infection, all cases of DMAC at Grady Memorial Hospital Infectious Disease Clinic (Atlanta) between 1985 and 1990 were reviewed, and a prospective study of the association of symptoms with DMAC was done. Between 1985 and 1990, DMAC occurred in 16% of patients with AIDS. Incidence increased from 5.7% in 1985-1988 to 23.3% in 1989-1990 (P less than .001). Median time from AIDS diagnosis to diagnosis of DMAC increased from 4.5 months in 1985-1988 to 8 months in 1989-1990 (P less than .02). In the prospective study, DMAC was seen only in persons with a CD4+ count less than 100 cells/mm3 and was associated with fever (P less than .03), anemia (P less than .001), weight loss (P less than .01), diarrhea (P less than .01), and elevated alkaline phosphatase (P less than .01). It is recommended that all such HIV-infected persons have mycobacterial blood cultures done.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • CD4-Positive T-Lymphocytes
  • Child
  • Female
  • Georgia / epidemiology
  • HIV Infections / complications*
  • Humans
  • Incidence
  • Leukocyte Count
  • Male
  • Middle Aged
  • Mycobacterium avium-intracellulare Infection / complications
  • Mycobacterium avium-intracellulare Infection / diagnosis*
  • Mycobacterium avium-intracellulare Infection / epidemiology
  • Prospective Studies
  • Retrospective Studies